BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23744743)

  • 1. Anticoagulation control with daily low-dose vitamin k to reduce clinically adverse outcomes and international normalized ratio variability: a systematic review and meta-analysis.
    Lam J; Schulman S; Witt DM; Vandvik PO; Qayyum F; Holbrook AM
    Pharmacotherapy; 2013 Nov; 33(11):1184-90. PubMed ID: 23744743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin K for improved anticoagulation control in patients receiving warfarin.
    Mahtani KR; Heneghan CJ; Nunan D; Roberts NW
    Cochrane Database Syst Rev; 2014 May; (5):CD009917. PubMed ID: 24832594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposed Criteria for the Use of Low-Dose Vitamin K Supplementation in Patients Using Vitamin K Antagonists: A Literature Review of a Clinical Controversy.
    Evans CE; Getchell KE; Ivy DR
    J Pharm Pract; 2018 Apr; 31(2):208-215. PubMed ID: 28610453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis.
    Khatib R; Ludwikowska M; Witt DM; Ansell J; Clark NP; Holbrook A; Wiercioch W; Schünemann H; Nieuwlaat R
    Blood Adv; 2019 Mar; 3(5):789-796. PubMed ID: 30850385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to optimal dosing of vitamin K antagonists.
    Witt DM
    Semin Thromb Hemost; 2012 Oct; 38(7):667-72. PubMed ID: 22893509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation.
    Lip GYH; Haguenoer K; Saint-Etienne C; Fauchier L
    Chest; 2014 Sep; 146(3):719-726. PubMed ID: 24722973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How safe is acetaminophen use in patients treated with vitamin K antagonists? A systematic review and meta-analysis.
    Caldeira D; Costa J; Barra M; Pinto FJ; Ferreira JJ
    Thromb Res; 2015 Jan; 135(1):58-61. PubMed ID: 25456003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review.
    Wan Y; Heneghan C; Perera R; Roberts N; Hollowell J; Glasziou P; Bankhead C; Xu Y
    Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):84-91. PubMed ID: 20031794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-vitamin K antagonist oral anticoagulants compared with warfarin at different levels of INR control in atrial fibrillation: A meta-analysis of randomized trials.
    Carmo J; Ferreira J; Costa F; Carmo P; Cavaco D; Carvalho S; Morgado F; Adragão P; Mendes M
    Int J Cardiol; 2017 Oct; 244():196-201. PubMed ID: 28679480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin. A randomised trial.
    Boonyawat K; Wang L; Lazo-Langner A; Kovacs MJ; Yeo E; Schnurr T; Schulman S; Crowther MA
    Thromb Haemost; 2016 Aug; 116(3):480-5. PubMed ID: 27346552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression.
    Mearns ES; White CM; Kohn CG; Hawthorne J; Song JS; Meng J; Schein JR; Raut MK; Coleman CI
    Thromb J; 2014; 12():14. PubMed ID: 25024644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.
    Sawicka-Powierza J; Buczkowski K; Chlabicz S; Gugnowski Z; Powierza K; Ołtarzewska AM
    Kardiol Pol; 2018; 76(4):764-769. PubMed ID: 29313558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.
    Crowther MA; Ageno W; Garcia D; Wang L; Witt DM; Clark NP; Blostein MD; Kahn SR; Vesely SK; Schulman S; Kovacs MJ; Rodger MA; Wells P; Anderson D; Ginsberg J; Selby R; Siragusa S; Silingardi M; Dowd MB; Kearon C
    Ann Intern Med; 2009 Mar; 150(5):293-300. PubMed ID: 19258557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin K supplementation to decrease variability of International Normalized Ratio in patients on vitamin K antagonists: a literature review.
    Ford SK; Moll S
    Curr Opin Hematol; 2008 Sep; 15(5):504-8. PubMed ID: 18695375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis.
    Franchini M; Mengoli C; Cruciani M; Bonfanti C; Mannucci PM
    J Thromb Haemost; 2014 Sep; 12(9):1480-7. PubMed ID: 25040440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis to assess the quality of international normalized ratio control and associated outcomes in venous thromboembolism patients.
    Mearns ES; Kohn CG; Song JS; Hawthorne J; Meng J; White CM; Raut MK; Schein JR; Coleman CI
    Thromb Res; 2014 Aug; 134(2):310-9. PubMed ID: 24935672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature.
    Dentali F; Crowther M; Galli M; Pomero F; Garcia D; Clark N; Spadafora L; Witt DM; Ageno W;
    Semin Thromb Hemost; 2016 Sep; 42(6):671-81. PubMed ID: 27232386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
    Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.